lundi 29 juin 2015

Onco Actu du 29 juin 2015

2. Etiologie

Viagra, Melanoma And The Problem With Big Data [Forbes]

3.1 Tabac

E-cigarettes and health — here's what the evidence actually says [Vox]

Consumers unclear about risks or benefits of e-cigarettes [Reuters]

5. Traitements

Amgen Distributes Important Safety Updates on Prolia® [ASCO]

Overcoming Drug Resistance: The EGFR Enigma, Part 2 [CANCER RESEARCH Catalyst]

5.12 Immunothérapies

Immunotherapy: 5 Ways to Stop Cancer [Cancer Research Institute]

5.3 Traitements - FDA, EMA,...

Early dialogue to support development of medicines for children [EMA]

5.3.4 Traitements - AMM (FDA, EMA)

Roche’s Perjeta recommended for approval in EU for use before surgery in HER2-positive early breast cancer [Roche]

Novartis scores recommendation from EMA for myeloma drug Farydak [FiercePharma]

Novartis drug Farydak® recommended by CHMP for EU approval to treat multiple myeloma, providing patients a new mechanism of action [Novartis]

First HDAC inhibitor for treatment of multiple myeloma recommended for approval in EU [EMA]

5.4 Traitements - Economie

Merck cancer drugs and Sanofi, Amgen cardio meds have formularies on high alert [FiercePharma]

6. Lutte contre les cancers

Baroness Delyth Morgan appointed as chair of the National Cancer Research Institute [ecancer - News]

Listening To The Voice Of The Patient In Precision Medicine [Forbes]

6.11 Patients

Glastonbury 1, Cancer 0: ‘It's a shame we didn't tick Foo Fighters off the bucket list’ [The Guardian]

6.4 Médico-éco

Cancer Research UK invests £15 million in new major centres [Cancer Research UK]

How an Oregon cancer institute raised a billion dollars [Nature News & Comment]

6.6 Publications

No impact without data access [Nature Genetics]

6.7 DMP, Big Data & applis

NHS patient data plans unachievable, review finds |[The Guardian]